237 related articles for article (PubMed ID: 21987539)
21. Alternatives to the quality-adjusted life year: How well do they address common criticisms?
Rand LZ; Melendez-Torres GJ; Kesselheim AS
Health Serv Res; 2023 Apr; 58(2):433-444. PubMed ID: 36537647
[TBL] [Abstract][Full Text] [Related]
22. 'It takes two to tango': Bridging the gap between country need and vaccine product innovation.
Archer RA; Kapoor R; Isaranuwatchai W; Teerawattananon Y; Giersing B; Botwright S; Luttjeboer J; Hutubessy RCW
PLoS One; 2020; 15(6):e0233950. PubMed ID: 32520934
[TBL] [Abstract][Full Text] [Related]
23. Expanded HTA: Enhancing Fairness and Legitimacy.
Daniels N; Porteny T; Urritia J
Int J Health Policy Manag; 2015 Nov; 5(1):1-3. PubMed ID: 26673643
[TBL] [Abstract][Full Text] [Related]
24. Supporting the Use of Health Technology Assessments by Decision-Makers.
Polisena J; Lavis JN; Juzwishin D; McLean-Veysey P; Graham ID; Harstall C; Martin J
Healthc Policy; 2015 May; 10(4):10-5. PubMed ID: 26142355
[TBL] [Abstract][Full Text] [Related]
25. Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives.
Kaló Z; Petykó ZI; Fricke FU; Maniadakis N; Tesař T; Podrazilová K; Espin J; Inotai A
Cost Eff Resour Alloc; 2021 Jul; 19(1):42. PubMed ID: 34266465
[TBL] [Abstract][Full Text] [Related]
26. Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis.
Broekhuizen H; Groothuis-Oudshoorn CG; Hauber AB; Jansen JP; IJzerman MJ
BMC Med Inform Decis Mak; 2015 Dec; 15():102. PubMed ID: 26626279
[TBL] [Abstract][Full Text] [Related]
27. Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective.
de Jong AJ; Shahid N; Zuidgeest MGP; Santa-Ana-Tellez Y; Hogervorst M; Goettsch W; Traore H; de Boer A; Gardarsdottir H;
Value Health; 2024 Mar; 27(3):294-300. PubMed ID: 38043711
[TBL] [Abstract][Full Text] [Related]
28. Incorporating Prior Data in Quantitative Benefit-Risk Assessments: Case Study of a Bayesian Method.
Dharmarajan S; Yuan Z; Chen YF; Lackey L; Mukhopadhyay S; Singh P; Tiwari R
Ther Innov Regul Sci; 2024 May; 58(3):415-422. PubMed ID: 38265736
[TBL] [Abstract][Full Text] [Related]
29. How to support the application of multiple criteria decision analysis? Let us start with a comprehensive taxonomy.
Cinelli M; Kadziński M; Gonzalez M; Słowiński R
Omega; 2020; 96():. PubMed ID: 33746337
[TBL] [Abstract][Full Text] [Related]
30. National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and Ethiopia.
Jansen M; Spasenoska D; Nadjib M; Ararso D; Hutubessy R; Kahn AL; Lambach P
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543971
[TBL] [Abstract][Full Text] [Related]
31. Health technology assessment in middle-income countries: recommendations for a balanced assessment system.
Dankó D
J Mark Access Health Policy; 2014; 2():. PubMed ID: 27226832
[TBL] [Abstract][Full Text] [Related]
32. Wastewater management decision-making: A literature review and synthesis.
Ko D; Norton JW; Daigger GT
Water Environ Res; 2024 Apr; 96(4):e11024. PubMed ID: 38666418
[TBL] [Abstract][Full Text] [Related]
33. Multi-Stakeholder Decision Aid for Improved Prioritization of the Public Health Impact of Climate Sensitive Infectious Diseases.
Hongoh V; Michel P; Gosselin P; Samoura K; Ravel A; Campagna C; Cissé HD; Waaub JP
Int J Environ Res Public Health; 2016 Apr; 13(4):419. PubMed ID: 27077875
[TBL] [Abstract][Full Text] [Related]
34. Priority setting in the Brazilian emergency medical service: a multi-criteria decision analysis (MCDA).
Frazão TDC; Santos AFAD; Camilo DGG; da Costa Júnior JF; de Souza RP
BMC Med Inform Decis Mak; 2021 May; 21(1):151. PubMed ID: 33957933
[TBL] [Abstract][Full Text] [Related]
35. Prioritization of livestock transboundary diseases in Belgium using a multicriteria decision analysis tool based on drivers of emergence.
Bianchini J; Humblet MF; Cargnel M; Van der Stede Y; Koenen F; de Clercq K; Saegerman C
Transbound Emerg Dis; 2020 Jan; 67(1):344-376. PubMed ID: 31520577
[TBL] [Abstract][Full Text] [Related]
36. Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia.
Pinazo MJ; Cidoncha A; Gopal G; Moriana S; Saravia R; Torrico F; Gascon J
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009249. PubMed ID: 33770076
[TBL] [Abstract][Full Text] [Related]
37. Reference Case Methods for Expert Elicitation in Health Care Decision Making.
Bojke L; Soares MO; Claxton K; Colson A; Fox A; Jackson C; Jankovic D; Morton A; Sharples LD; Taylor A
Med Decis Making; 2022 Feb; 42(2):182-193. PubMed ID: 34271832
[TBL] [Abstract][Full Text] [Related]
38. Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop.
Al-Omar HA; Aljuffali IA; Solà-Morales O
Saudi Pharm J; 2021 Sep; 29(9):946-954. PubMed ID: 34588840
[TBL] [Abstract][Full Text] [Related]
39. Health Technology Assessment of Intensive Care Ventilators for Pediatric Patients.
Andellini M; Faggiano F; Picardo SG; Testa G; Perrotta D; Bianchi R; Nocchi F; Capussotto C; Bassanelli E; Derrico P; Pirozzi N; Pecchia L; Ritrovato M
Children (Basel); 2021 Nov; 8(11):. PubMed ID: 34828698
[TBL] [Abstract][Full Text] [Related]
40. GIS automated multicriteria analysis (GAMA) method for susceptibility modelling.
Domazetović F; Šiljeg A; Lončar N; Marić I
MethodsX; 2019; 6():2553-2561. PubMed ID: 31908982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
